Psychosis

Ketogenic Diet, in a First Randomized Trial, Correlates With Symptom Improvement in Schizophrenia & Bipolar Disorder With Psychosis
A team led by BBRF grantees and Scientific Council members has reported the first-ever randomized, controlled trial to assess the effects of a ketogenic diet on psychiatric symptoms, metabolism, and… Read More
In a First Episode of Psychosis (FEP), Distinct Symptoms, Cognition, and EEG Measures Seen in Cannabis Users vs. Non-Users
A team led by a two-time BBRF grantee has published research suggesting the possibility that cannabis use in some individuals may be associated with a distinct subtype of first-episode psychosis (FEP… Read More
In Youths at High Risk of Psychosis, a Marker in White Blood Cells May Be an Important Indicator of Response to Therapy
Researchers have reported new evidence bearing on their multi-year effort to identify clinically useful markers of high risk for the onset of psychosis in young people. Read More
Study: Following Cannabis Commercialization, Occasional Use in Those With Psychosis History Increased Much More Than in General Population, Posing Potential Risk
What impact has legalization and commercialization of recreational cannabis had on people with schizophrenia and other disorders involving psychosis? It’s an important question, particularly in view… Read More
In First-Episode Psychosis Patients, Machine Learning Predicted Illness Trajectories to Potentially Improve Outcomes
There is broad agreement among psychiatrists, based on many years of clinical experience, that early treatment following a first episode of psychosis (FEP) provides the best chance for improving a… Read More